(Q44507626)

English

Determination of simvastatin-derived HMG-CoA reductase inhibitors in biomatrices using an automated enzyme inhibition assay with radioactivity detection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Determination of simvastatin-derived HMG-CoA reductase inhibitors in biomatrices using an automated enzyme inhibition assay with radioactivity detection (English)

1 reference

Europe PubMed Central

3 December 2017

0 references

author name string

Lida Liu

1

1 reference

Europe PubMed Central

3 December 2017

Rena Zhang

2

1 reference

Europe PubMed Central

3 December 2017

Jamie J Zhao

3

1 reference

Europe PubMed Central

3 December 2017

John D Rogers

4

1 reference

Europe PubMed Central

3 December 2017

John Y K Hsieh

5

1 reference

Europe PubMed Central

3 December 2017

Wei Fang

6

1 reference

Europe PubMed Central

3 December 2017

Bogdan K Matuszewski

7

1 reference

Europe PubMed Central

3 December 2017

Michael R Dobrinska

8

1 reference

Europe PubMed Central

3 December 2017

publication date

1 April 2003

1 reference

Europe PubMed Central

3 December 2017

Journal of Pharmaceutical and Biomedical Analysis

1 reference

Europe PubMed Central

3 December 2017

32

1 reference

Europe PubMed Central

3 December 2017

1

1 reference

Europe PubMed Central

3 December 2017

107-123

1 reference

Europe PubMed Central

3 December 2017

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of simvastatin (MK-733).

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin: the clinical profile

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by high-performance liquid chromatography with UV detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of simvastatin and its active metabolite in human plasma by column-switching high-performance liquid chromatography with fluorescence detection after derivatization with 1-bromoacetylpyrene

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A selected ion monitoring method for quantifying simvastatin and its acid form in human plasma, using the ferroceneboronate derivative.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of simvastatin and its beta-hydroxy acid in human plasma by liquid-liquid cartridge extraction and liquid chromatography/tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of liquid chromatography mobile phase buffer contents on the ionization and fragmentation of analytes in liquid chromatographic/ionspray tandem mass spectrometric determination

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Robotic inhibition assay for determination of HMG-CoA reductase inhibitors in human plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2803%2900023-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0731-7085(03)00023-2

1 reference

Europe PubMed Central

3 December 2017

release_wdglj2qi3zhczn6e2bc7ouoibi

1 reference

https://api.fatcat.wiki/v0/release/wdglj2qi3zhczn6e2bc7ouoibi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44507626&oldid=2025949833"